ARKZ yields 100.41% · JNJ yields 2.13%● Live data
📍 ARKZ pulled ahead of the other in Year 1
Combined, ARKZ + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ARKZ + JNJ for your $10,000?
ARKZ holds standardized, cash-settled Ether futures traded on the Chicago Mercantile Exchange (CME). With a targeted allocation of over 25% of total assets, the fund operates through a subsidiary structure based in the Cayman Islands. The fund employs a rolling strategy that seeks optimal roll yield by investing in contracts with the most attractive combination of cost, liquidity, and other relevant factors. Typically, these contracts have monthly or quarterly contract periods. Moreover, the fund may invest in front-month Ether Futures contracts and usually rolls to the next nearby contracts at the time believed to generate the greatest roll yield. To provide liquidity and collateral for Ether Futures investments, the remaining assets are diversified into short-term cash instruments, including U.S. Treasury securities and money market instruments. Additionally, the fund may engage in leveraging through reverse repurchase agreements.
Full ARKZ Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.